Panel to take a call on doorstep medicine delivery

India's drug advisory body is considering the future of doorstep medicine delivery, initiated during the Covid-19 pandemic. The All-India Organisation of Chemists and Druggists is urging the government to withdraw the notification, alleging misuse by digital platforms and prioritizing profit over patient safety. A sub-committee will now examine the matter in detail before a decision is made.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pZ592OC
via IFTTT